BiotechTube
Home/EpiPharm/Dr. Rosemarie Sift Carter
DR

Dr. Rosemarie Sift Carter

Chief Executive Officer (CEO)

EpiPharm

Therapeutic Areas

DermatologyAesthetic Medicine

EpiPharm Pipeline

DrugIndicationPhase
Artemisinin-based Topical Formulation (Artemether)Seborrhoeic KeratosisPhase 2/3
Artemisinin-based Topical FormulationMelanocytic LesionsClinical-Stage
Proprietary Multi-Active Artemisia CompositionPrevention & Treatment of Dysplastic Epidermal Cell GrowthPreclinical/Clinical-Stage

Leadership Team at EpiPharm

DR
Dr. Robert Carter
Head of Development and Regulatory
PR
Prof. R. Haynes
Advisor, Medicinal Chemistry
PA
Prof. A. Dayan
Advisor, Preclinical Safety
DM
Dr. med. A Härtel
Medical Consultant
DA
Dr. A. Watkinson
Advisor, Formulation Development
View full EpiPharm profile